194 related articles for article (PubMed ID: 16336420)
21. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
[TBL] [Abstract][Full Text] [Related]
22. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
[TBL] [Abstract][Full Text] [Related]
23. Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients.
Charfen MA; Ipp E; Kaji AH; Saleh T; Qazi MF; Lewis RJ
Acad Emerg Med; 2009 May; 16(5):394-402. PubMed ID: 19302369
[TBL] [Abstract][Full Text] [Related]
24. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
Eriksson JG; Lehtovirta M; Ehrnström B; Salmela S; Groop L
J Intern Med; 2006 Jun; 259(6):553-60. PubMed ID: 16704555
[TBL] [Abstract][Full Text] [Related]
25. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
26. Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus.
Delorme S; Chiasson JL
Curr Opin Pharmacol; 2005 Apr; 5(2):184-9. PubMed ID: 15780829
[TBL] [Abstract][Full Text] [Related]
27. Hyperglycaemia and cardiovascular disease.
Bartnik M; Norhammar A; Rydén L
J Intern Med; 2007 Aug; 262(2):145-56. PubMed ID: 17645583
[TBL] [Abstract][Full Text] [Related]
28. [Insulin sensitivity and beta cell function in different glucose tolerance status].
Gómez-García A; Magaña-Garns P; Ruiz-García J; Alvarez-Aguilar C
Invest Clin; 2006 Jun; 47(2):155-66. PubMed ID: 16886777
[TBL] [Abstract][Full Text] [Related]
29. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome--the Chennai Urban Rural Epidemiology Study.
Gokulakrishnan K; Deepa R; Mohan V; Gross MD
Metabolism; 2006 Feb; 55(2):237-42. PubMed ID: 16423632
[TBL] [Abstract][Full Text] [Related]
30. [Usefulness of oral glucose tolerance test (OGTT) in output patients with advanced chronic renal failure (CRF)].
Rufino M; Barbero P; Hernández D; Torres A; Lorenzo V
Nefrologia; 2007; 27(1):30-7. PubMed ID: 17402877
[TBL] [Abstract][Full Text] [Related]
31. A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians - the Chennai Urban Rural Epidemiology Study (CURES-38).
Mohan V; Sandeep S; Deepa M; Gokulakrishnan K; Datta M; Deepa R
Diabetes Obes Metab; 2007 May; 9(3):337-43. PubMed ID: 17391160
[TBL] [Abstract][Full Text] [Related]
32. Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).
Chakarova N; Tankova T; Atanassova I; Dakovska L
Diabetes Res Clin Pract; 2009 Oct; 86(1):56-60. PubMed ID: 19674805
[TBL] [Abstract][Full Text] [Related]
33. Using common clinical data improves the prediction of abnormal glucose tolerance by the new criteria of impaired fasting glucose: Tehran lipid and glucose study.
Hadaegh F; Harati H; Ghasemi A; Tohidi M; Zabetian A; Mehrabi Y; Azizi F
Diabetes Res Clin Pract; 2007 Sep; 77(3):459-64. PubMed ID: 17350133
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes.
Zeymer U
Int J Cardiol; 2006 Feb; 107(1):11-20. PubMed ID: 16337493
[TBL] [Abstract][Full Text] [Related]
35. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
[TBL] [Abstract][Full Text] [Related]
36. Role of postprandial hyperglycemia in cardiovascular disease.
Fava S
Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):859-72. PubMed ID: 18570623
[TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome does not increase the risk of conversion of impaired glucose tolerance to diabetes in Asian Indians--Result of Indian diabetes prevention programme.
Ramachandran A; Snehalatha C; Satyavani K; Sivasankari S; Vijay V
Diabetes Res Clin Pract; 2007 May; 76(2):215-8. PubMed ID: 16982107
[TBL] [Abstract][Full Text] [Related]
38. [Reduced glucose tolerance as a risk factor of cardiovascular diseases].
Holmen J
Tidsskr Nor Laegeforen; 1994 Jun; 114(15):1700-3. PubMed ID: 8079281
[TBL] [Abstract][Full Text] [Related]
39. Early manifestation of cardiovascular disease risk factors in offspring of mothers with previous history of gestational diabetes mellitus.
Lee H; Jang HC; Park HK; Cho NH
Diabetes Res Clin Pract; 2007 Nov; 78(2):238-45. PubMed ID: 17499877
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry.
Ziegler D; Rathmann W; Meisinger C; Dickhaus T; Mielck A;
Eur J Pain; 2009 Jul; 13(6):582-7. PubMed ID: 18782673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
